FindTrial
Sign In

Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics

Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127262
Enrollment
Unknown
Registered
2026-06-28
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Sign the informed consent form and voluntarily participate in this study. 3. Patients with tumors definitively diagnosed by pathology and/or cytology, including those undergoing pathological examination of primary lesion biopsy specimens or gastroscopic/biliary endoscopic biopsy specimens (for esophageal cancer, hepatocellular carcinoma, gastric cancer, or cholangiocarcinoma).

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or breastfeeding; 2. Presence of surgical contraindications; 3. Presence of concomitant cognitive dysfunction, mental disorders, impaired consciousness, or unwillingness to cooperate; 4. Patients with two or more types of tumors;

Design outcomes

Primary

MeasureTime frame
Change in skeletal muscle index (SMI, cm^2/m^2);—

Countries

China

Contacts

Public ContactLi Kai

The First Affiliated Hospital of China Medical University

cmu_likai@163.com+86 24 83283556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026